{"id":55646,"date":"2015-04-04T15:32:45","date_gmt":"2015-04-04T19:32:45","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=55646"},"modified":"2015-04-05T00:41:12","modified_gmt":"2015-04-05T04:41:12","slug":"slim-pickings","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2015\/04\/04\/slim-pickings\/","title":{"rendered":"slim pickings&#8230;"},"content":{"rendered":"<div align=\"justify\" class=\"small\">When I wrote the last post [<a target=\"_blank\" href=\"http:\/\/1boringoldman.com\/index.php\/2015\/04\/02\/a-pilot\/\">a pilot&hellip;<\/a>], I was aware that there had been letters in the Lancet about the Morrison et al article, that I couldn&#8217;t access. They&#8217;re by statistically much more sophisticated critics than I, but have similar reservations and more. But I wanted to mention the opening to the authors&#8217; reply to the critics: <\/div>\n<blockquote>\n<div align=\"justify\"><em><strong><font color=\"#200020\">Authors&rsquo; reply<\/font><\/strong><\/em><\/div>\n<div align=\"justify\">Our trial was not designed to change clinical practice. It was a preliminary trial, which needs to be followed up by a larger, pragmatic multicentre study. It is important not to over<strong>&middot;<\/strong>interpret our data, and we explicitly advised against discontinuation of medication. <strong><font color=\"#800000\">We claimed the trial showed that cognitive therapy was safe and acceptable, not safe and effective<\/font><\/strong>&#8230;<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">And that&#8217;s true &#8211; that is exactly what they said at the end of the abstract&#8230;<\/div>\n<blockquote>\n<div align=\"justify\"><em><strong><font color=\"#200020\">INTERPRETATION<\/font><\/strong><\/em>:  <strong><font color=\"#800000\">Cognitive therapy significantly reduced psychiatric symptoms and seems  to be a <u>safe<\/u> and <u>acceptable<\/u> alternative for people with schizophrenia  spectrum disorders<\/font><\/strong> who have chosen not to take antipsychotic drugs.<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">&#8230;but I didn&#8217;t notice that subtle bit of wording the first time around [did you?]. There are some really fine <a href=\"http:\/\/1boringoldman.com\/index.php\/2015\/04\/02\/a-pilot\/#comment-261323\" target=\"_blank\">comments<\/a> to my last post &#8211; all worth taking a look at and adding lots of things I hadn&#8217;t really thought of. I&#8217;m not going to summarize them, but rather suggest you take a look. There&#8217;s also an excellent collection of articles on the topic at the<em><font color=\"#200020\"><a target=\"_blank\" href=\"http:\/\/www.thementalelf.net\/tag\/cbtp\/\"> Mental Elf<\/a><\/font><strong><font color=\"#200020\"> &#8211; CBTp<\/font><\/strong><\/em>. I went back and took a look at the prequel, Morrison et al&#8217;s <em>exploratory trial<\/em> prior to this <em>pilot trial<\/em>:<\/div>\n<blockquote>\n<div align=\"center\" class=\"big\"><a href=\"http:\/\/journals.cambridge.org\/action\/displayAbstract?fromPage=online&#038;aid=8521565&#038;fileId=S0033291711001899\" target=\"_blank\">Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial<\/a><\/div>\n<div align=\"center\">by A. P. Morrison, P. Hutton, M. Wardle, H. Spencer, S. Barratt A. Brabban, P. Callcott, T. Christodoulides, R. Dudley, P. French, V. Lumley, S. J. Tai and D. Turkington<\/div>\n<div align=\"center\" class=\"middle\"><strong><font color=\"#200020\">Psychological Medicine<\/font><\/strong>. 2012 42[05]:1049-1056.<\/div>\n<div align=\"center\" class=\"middle\">[<a href=\"http:\/\/www.mentalhealthexcellence.org\/wp-content\/uploads\/2013\/09\/Morrisonetal2011CTwithnomeds.pdf\" target=\"_blank\">full text on-line<\/a>]   <\/div>\n<p>   <\/p>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Background<\/font><\/strong><\/u>  Although antipsychotic medication is the first line of treatment for  schizophrenia, many service users choose to refuse or discontinue their  pharmacological treatment. Cognitive therapy (CT) has been shown to be  effective when delivered in combination with antipsychotic medication,  but has yet to be formally evaluated in its absence. This study  evaluates CT for people with psychotic disorders who have not been  taking antipsychotic medication for at least 6 months.<\/div>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Method<\/font><\/strong><\/u>  Twenty participants with schizophrenia spectrum disorders received CT  in an open trial. Our primary outcome was psychiatric symptoms measured  using the Positive and Negative Syndromes Scale [PANSS], which was  administered at baseline, 9 months [end of treatment] and 15 months [follow-up]. Secondary outcomes were dimensions of hallucinations and  delusions, self-rated recovery and social functioning.<\/div>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Results<\/font><\/strong><\/u> <em>T<\/em>  tests and Wilcoxon&#8217;s signed ranks tests revealed significant beneficial  effects on all primary and secondary outcomes at end of treatment<u><strong><font color=\"#200020\"><img loading=\"lazy\" decoding=\"async\" width=\"180\" vspace=\"4\" hspace=\"4\" height=\"140\" border=\"0\" align=\"right\" src=\"http:\/\/1boringoldman.com\/images\/morrison-6.jpg\" \/><\/font><\/strong><\/u> and  follow-up, with the exception of self-rated recovery at end of  treatment. Cohen&#8217;s <em>d<\/em> effect sizes were moderate to large [for PANSS total, <em>d<\/em>=0.85, 95% CI 0.32&ndash;1.35 at end of treatment; <em>d<\/em>=1.26,  95% CI 0.66&ndash;1.84 at follow-up]. A response rate analysis found that 35%  and 50% of participants achieved at least a 50% reduction in PANSS  total scores by end of therapy and follow-up respectively. No patients  deteriorated significantly.<\/div>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Conclusions<\/font><\/strong><\/u>  This study provides preliminary evidence that CT is an acceptable and  effective treatment for people with psychosis who choose not to take  antipsychotic medication. An adequately powered randomized controlled  trial is warranted.<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">Again, I had trouble reproducing their analyses [and again, access to the raw dataset would&#8217;ve been useful to figure out why]. Notice the wording:<\/div>\n<blockquote>\n<div align=\"justify\"><u><strong><font color=\"#200020\">Conclusions<\/font><\/strong><\/u> <strong><font color=\"#990000\">  This study provides preliminary evidence that CT is an <u>acceptable<\/u> and   <u>effective<\/u> treatment for people with psychosis who choose not to take   antipsychotic medication.<\/font><\/strong> An adequately powered randomized controlled  trial is warranted.<\/div>\n<\/blockquote>\n<div align=\"justify\" class=\"small\">Here is the Primary Outcome variable [<font color=\"#200020\">PANSS<sub>total<\/sub><\/font>] for the two studies [with 95% CI]:<\/div>\n<div align=\"center\" class=\"small\"><img loading=\"lazy\" decoding=\"async\" width=\"451\" vspace=\"7\" height=\"240\" border=\"0\" src=\"http:\/\/1boringoldman.com\/images\/morrison-7.gif\" \/><\/div>\n<div align=\"justify\" class=\"small\">It looks a lot like any number of the Clinical Drug Trials I&#8217;ve vetted before. Slim pickings [<em>slim to none<\/em>]&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>When I wrote the last post [a pilot&hellip;], I was aware that there had been letters in the Lancet about the Morrison et al article, that I couldn&#8217;t access. They&#8217;re by statistically much more sophisticated critics than I, but have similar reservations and more. But I wanted to mention the opening to the authors&#8217; reply [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-55646","post","type-post","status-publish","format-standard","hentry","category-opinion"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/55646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=55646"}],"version-history":[{"count":57,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/55646\/revisions"}],"predecessor-version":[{"id":55704,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/55646\/revisions\/55704"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=55646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=55646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=55646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}